ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,419.20
0.00%
다우존스 지수
38,675.68
0.00%
Bitcoin
64,106.27
0.17%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Astria Therapeutics Inc (ATXS)

  7. Astria Therapeutics Inc (ATXS) 뉴스

ATXS Astria Therapeutics Inc

9.55
0.00 (0.00%)
시간외 단일가
최종 업데이트: 20:40:41
15분 지연
기업명 주식 심볼 시장 주식 타입
Astria Therapeutics Inc ATXS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 9.55 20:40:41
개장가 저가 고가 종가 전일 종가
9.55
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
09/04/202421:00BWAstria Therapeutics Appoints Sunil Agarwal to Its Board of..
04/04/202405:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
25/03/202420:30BWAstria Therapeutics Announces Positive Initial..
06/03/202406:10BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
05/03/202407:22EDGAR2Form 8-K - Current report
05/03/202407:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/03/202406:10BWAstria Therapeutics Reports Fourth Quarter and Full Year..
05/03/202406:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/02/202422:00BWAstria Therapeutics to Present at Upcoming American Academy..
15/02/202405:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202405:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202422:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202422:00BWAstria Therapeutics to Present at Upcoming Oppenheimer 34th..
06/02/202406:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
31/01/202423:00EDGAR2Form 8-K - Current report
31/01/202422:59EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
31/01/202407:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202423:08BWAstria Therapeutics Announces Pricing of $125 Million..
30/01/202420:01EDGAR2Form 8-K - Current report
30/01/202406:39EDGAR2Form 144 - Report of proposed sale of securities
17/01/202406:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/01/202422:30EDGAR2Form 8-K - Current report
03/01/202406:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
29/12/202304:09EDGAR2Form S-3/A - Registration statement under Securities Act of..
21/12/202306:30EDGAR2Form 8-K - Current report
15/12/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
05/12/202306:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
27/11/202322:00BWAstria Therapeutics to Present STAR-0215 Data at the 2023..
21/11/202322:00BWAstria Therapeutics to Present at Upcoming 6th Annual..
14/11/202306:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:06EDGAR2Form 8-K - Current report
13/11/202322:00BWAstria Therapeutics Reports Third Quarter Financial Results..
10/11/202322:00BWAstria Therapeutics Presents New Phase 1a Data Confirming..
09/11/202322:00BWAstria Therapeutics to Present at Upcoming Jefferies London..
03/11/202321:10BWAstria Therapeutics to Present New STAR-0215 Data at the..
03/11/202305:00BWAstria Therapeutics Announces Inducement Grants Under Nasdaq..
30/10/202321:00BWAstria Therapeutics to Report Third Quarter 2023 Financial..
13/10/202306:04EDGAR2Form 8-K - Current report
13/10/202306:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202321:00EDGAR2Form 8-K - Current report
12/10/202308:14BWAstria Therapeutics Announces Pricing of $64 Million..
12/10/202306:14EDGAR2Form 8-K - Current report

최근 히스토리

NASDAQ
ATXS
Astria Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유